{
    "clinical_study": {
        "@rank": "159800", 
        "acronym": "ARTS-HF Japan", 
        "arm_group": [
            {
                "arm_group_label": "BAY94-8862 (2.5 mg)", 
                "arm_group_type": "Experimental", 
                "description": "2.5 mg BAY94-8862 tablet and placebo capsule once daily in the morning, with possible up-titration to 5 mg once daily at Visit 6 (Day 30), and sham up-titration at Visit 8 (Day 60), based on the value of serum potassium"
            }, 
            {
                "arm_group_label": "BAY94-8862 (5 mg)", 
                "arm_group_type": "Experimental", 
                "description": "5 mg BAY94-8862 tablet and placebo capsule once daily in the morning, with possible up-titration to 10 mg once daily at Visit 6 (Day 30), and sham up-titration at Visit 8 (Day 60), based on the value of serum potassium"
            }, 
            {
                "arm_group_label": "Eplerenone", 
                "arm_group_type": "Active Comparator", 
                "description": "25 mg eplerenone every other day, i.e. one 25 mg eplerenone capsule on Day 1, Day 3, Day 5, etc. in the morning, 1 placebo capsule on Day 2, Day 4, Day 6, etc. in the morning, and 1 placebo tablet once daily in the morning, with possible up-titration to 25 mg eplerenone once daily at Visit 6 (Day 30), i.e. one 25 mg eplerenone capsule once daily in the morning and 1 placebo tablet once daily in the morning, and a possible up-titration to 25 mg once daily [if not performed at Visit 6 (Day 30)] or to 50 mg once daily [if up-titrated to 25 mg once daily at Visit 6 (Day 30)] at Visit 8 (Day 60), based on the value of serum potassium"
            }, 
            {
                "arm_group_label": "BAY94-8862 (7.5 mg)", 
                "arm_group_type": "Experimental", 
                "description": "7.5 mg BAY94-8862 tablet and placebo capsule once daily in the morning, with possible up-titration to 15 mg once daily at Visit 6 (Day 30), and sham up-titration at Visit 8 (Day 60), based on the value of serum potassium Note: This treatment group may be introduced into the study or not after safety and tolerability of these doses has been assessed by an independent Data Monitoring Committee (DMC) (1st dose recommendation DMC meeting)."
            }, 
            {
                "arm_group_label": "BAY94-8862 (10 mg)", 
                "arm_group_type": "Experimental", 
                "description": "10 mg BAY94-8862 tablet and placebo capsule once daily in the morning, with possible up-titration to 20 mg once daily at Visit 6 (Day 30), and sham up-titration at Visit 8 (Day 60), based on the value of serum potassium Note: Only in case the above mentioned additional treatment arm (BAY94-8862, 7.5 mg) has been added, a second dose decision meeting of the DMC will take place, Again safety and tolerability of all doses will be assessed by an independent DMC (2nd dose recommendation DMC meeting). Based on this data, none or up to two treatment groups (BAY94-8862, 10 mg and BAY94-8862,15 mg) may be introduced into the study."
            }, 
            {
                "arm_group_label": "BAY94-8862 (15 mg)", 
                "arm_group_type": "Experimental", 
                "description": "15 mg BAY94-8862 tablet and placebo capsule once daily in the morning, with possible up-titration to 20 mg once daily at Visit 6 (Day 30), and sham up-titration at Visit 8 (Day 60), based on the value of serum potassium Note: Only in case the above mentioned additional treatment arm (BAY94-8862, 7.5 mg) has been added, a second dose decision meeting of the DMC will take place, Again safety and tolerability of all doses will be assessed by an independent DMC (2nd dose recommendation DMC meeting). Based on this data, none or up to two treatment groups (BAY94-8862, 10 mg and BAY94-8862,15 mg) may be introduced into the study."
            }
        ], 
        "brief_summary": {
            "textblock": "This study will be conducted in subjects with clinical diagnosis of worsening chronic heart\n      failure and either type 2 diabetes mellitus (DM) with or without chronic kidney disease\n      (CKD) or moderate CKD alone treated with evidence-based therapy for heart failure (HF) for\n      at least 3 months prior to emergency presentation to hospital using a multi-center,\n      randomized, adaptive, double-blind, double-dummy, comparator-controlled, parallel-group\n      design.\n\n      Primary objective of the study is to investigate efficacy [percentage of subjects with a\n      relative decrease in N-terminal prohormone B-type natriuretic peptide (NT-proBNP) of more\n      than 30% from baseline to Visit 10 (Day 90)] and safety of different oral doses of\n      BAY94-8862 given once daily."
        }, 
        "brief_title": "Phase IIb Safety and Efficacy Study of BAY94-8862 in Subjects With Worsening Chronic Heart Failure and Left Ventricular Systolic Dysfunction and Either Type 2 Diabetes Mellitus With or Without Chronic Kidney Disease or Moderate Chronic Kidney Disease Alone", 
        "completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Heart Failure", 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 2", 
                "Heart Failure", 
                "Kidney Diseases", 
                "Renal Insufficiency, Chronic", 
                "Kidney Failure, Chronic", 
                "Ventricular Dysfunction, Left"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subjects with worsening chronic heart failure requiring emergency presentation to\n             hospital and treatment with intravenous (IV) diuretics at hospital\n\n          -  Subjects with either type 2 DM or moderate CKD\n\n        Exclusion Criteria:\n\n          -  Acute de-novo heart failure or acute inflammatory heart disease, e.g. acute\n             myocarditis\n\n          -  Acute coronary syndrome (ACS) (elevated cardiac troponins which are not caused by an\n             ACS are not an exclusion criterion) in the last 30 days prior to the screening visit\n\n          -  Cardiogenic shock\n\n          -  Valvular heart disease requiring surgical intervention during the course of the study\n\n          -  Subjects with left ventricular assistance device or waiting for heart transplantation\n\n          -  Stroke or transient ischemic cerebral attack in the last 3 months prior to the\n             screening visit\n\n          -  Addison's disease"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "96", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 30, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01955694", 
            "org_study_id": "16815"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "BAY94-8862 (2.5 mg)", 
                    "BAY94-8862 (5 mg)", 
                    "BAY94-8862 (7.5 mg)", 
                    "BAY94-8862 (10 mg)", 
                    "BAY94-8862 (15 mg)"
                ], 
                "description": "2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg, and 20 mg of BAY94-8862 tablets", 
                "intervention_name": "BAY94-8862", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Eplerenone", 
                "description": "INSPRA 25 and 50 mg tablets (MAH: Pfizer) will be used for eplerenone 25 and 50 mg tablets", 
                "intervention_name": "Eplerenone", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "BAY94-8862 (2.5 mg)", 
                    "BAY94-8862 (5 mg)", 
                    "Eplerenone", 
                    "BAY94-8862 (7.5 mg)", 
                    "BAY94-8862 (10 mg)", 
                    "BAY94-8862 (15 mg)"
                ], 
                "description": "matching placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Eplerenone"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "BAY94-8862", 
            "MR antagonist", 
            "Heart failure", 
            "Japanese patients"
        ], 
        "lastchanged_date": "May 15, 2014", 
        "link": [
            {
                "description": "Click here and search for drug information provided by the FDA.", 
                "url": "http://www.fda.gov/cder/drug/DrugSafety/DrugIndex.htm"
            }, 
            {
                "description": "Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.", 
                "url": "http://www.fda.gov/medwatch/safety.htm"
            }
        ], 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Seto", 
                        "country": "Japan", 
                        "state": "Aichi", 
                        "zip": "489-8642"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Toyota", 
                        "country": "Japan", 
                        "state": "Aichi", 
                        "zip": "471-8513"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kamogawa", 
                        "country": "Japan", 
                        "state": "Chiba", 
                        "zip": "296-0041"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kamogawa", 
                        "country": "Japan", 
                        "state": "Chiba", 
                        "zip": "296-8602"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Matsuyama", 
                        "country": "Japan", 
                        "state": "Ehime", 
                        "zip": "790-0067"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chikushino", 
                        "country": "Japan", 
                        "state": "Fukuoka", 
                        "zip": "818-8516"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Amagasaki", 
                        "country": "Japan", 
                        "state": "Hyogo", 
                        "zip": "660-0828"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kobe", 
                        "country": "Japan", 
                        "state": "Hyogo", 
                        "zip": "654-0155"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kobe", 
                        "country": "Japan", 
                        "state": "Hyogo", 
                        "zip": "650-0047"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Higashiibaraki", 
                        "country": "Japan", 
                        "state": "Ibaraki", 
                        "zip": "311-3193"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hiratsuka", 
                        "country": "Japan", 
                        "state": "Kanagawa", 
                        "zip": "254-8502"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kawasaki", 
                        "country": "Japan", 
                        "state": "Kanagawa", 
                        "zip": "211-8533"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Yokohama", 
                        "country": "Japan", 
                        "state": "Kanagawa", 
                        "zip": "245-8575"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sendai", 
                        "country": "Japan", 
                        "state": "Miyagi", 
                        "zip": "983-8520"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Naha", 
                        "country": "Japan", 
                        "state": "Okinawa", 
                        "zip": "900-0005"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Naha", 
                        "country": "Japan", 
                        "state": "Okinawa", 
                        "zip": "902-8511"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Urasoe", 
                        "country": "Japan", 
                        "state": "Okinawa", 
                        "zip": "901-2132"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sayama", 
                        "country": "Japan", 
                        "state": "Saitama", 
                        "zip": "350-1323"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sayama", 
                        "country": "Japan", 
                        "state": "Saitama", 
                        "zip": "350-1323"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kusatsu", 
                        "country": "Japan", 
                        "state": "Shiga", 
                        "zip": "525-8585"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Shinjuku-ku", 
                        "country": "Japan", 
                        "state": "Tokyo", 
                        "zip": "162-8666"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Shinjuku-ku", 
                        "country": "Japan", 
                        "state": "Tokyo", 
                        "zip": "162-8655"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kofu", 
                        "country": "Japan", 
                        "state": "Yamanashi", 
                        "zip": "400-8506"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Fukuoka", 
                        "country": "Japan", 
                        "zip": "810-0001"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kagoshima", 
                        "country": "Japan", 
                        "zip": "892-0853"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kyoto", 
                        "country": "Japan", 
                        "zip": "607-8062"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Okayama", 
                        "country": "Japan", 
                        "zip": "700-8607"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Osaka", 
                        "country": "Japan", 
                        "zip": "558-8558"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Shizuoka", 
                        "country": "Japan", 
                        "zip": "420-8630"
                    }
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "Japan"
        }, 
        "number_of_arms": "6", 
        "official_title": "A Randomized, Double-blind, Double-dummy, Multi-center Study to Assess Safety and Efficacy of BAY94-8862 in Japanese Subjects With Emergency Presentation at the Hospital Because of Worsening Chronic Heart Failure With Left Ventricular Systolic Dysfunction and Either Type 2 Diabetes Mellitus With or Without Chronic Kidney Disease or Moderate Chronic Kidney Disease Alone Versus Eplerenone", 
        "overall_contact": {
            "email": "clinical-trials-contact@bayerhealthcare.com", 
            "last_name": "Bayer Clinical Trials Contact"
        }, 
        "overall_official": {
            "affiliation": "Bayer", 
            "last_name": "Bayer Study Director", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Japan: Pharmaceuticals and Medical Devices Agency", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "The percentage of subjects with a relative decrease in N-terminal prohormone B-type natriuretic peptide of more than 30% from baseline to Visit 10", 
            "safety_issue": "No", 
            "time_frame": "From baseline to 90 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01955694"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Change in serum potassium", 
            "safety_issue": "Yes", 
            "time_frame": "From baseline to 90 days"
        }, 
        "source": "Bayer", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Bayer", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}